Australia Clears Novartis Buy Of Alcon Without Key Eye-care Line
This article was originally published in PharmAsia News
Australian authorities have given their permission for the merger of Switzerland's Novartis AG and Alcon Laboratories, based in the United States, but incorporated in Switzerland
You may also be interested in...
Companies including Dr Reddy’s will consider investing in new API units if the Indian government tweaks its incentive scheme to permit exports of surplus production. Other suggested changes to the $1.3bn stimulus, aimed at enhancing the country's medicines security, include extending incentives to brownfield expansions and removing restrictions on a change in product mix.
The Global Generics & Biosimilars Awards 2020 will take place on 3 November as a digital event, with a newly-extended entry deadline date of 14 August.
Developed by Japan’s national research institute, the supercomputer has been tasked with characterizing the SARS-CoV-2 virus, identifying therapeutic molecules, modeling infection spread and socio-economic impact.